PharmaVitae explores Astellas’s prescription pharmaceutical performance and outlook over 2017–27. PharmaVitae analyses include quarterly earnings coverage and provide timely updates to company product forecasts. The full company profile encompasses analysis on corporate strategy, portfolio analysis, pipeline potential, and financial performance.

This Datamonitor Healthcare report contains a PharmaVitae Company Analysis module.